Jean Jacques Bienaime - Director at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jean Jacques Bienaime since 7/7/2023

Holdings reported by Jean Jacques Bienaime for Keros Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 200 $9.06 K $45.29 Jun 1, 2024 Direct
Stock Option (right to buy) 17,600 Jun 3, 2024 Direct Common Stock

Transactions reported by Jean Jacques Bienaime for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership